We are live on
!
Find out more
ORPH
Orphazyme A/S
ORPH
ORPH
Delisted
ORPH was delisted on the 30th of March, 2022.
5 hedge funds and large institutions have $1.84M invested in Orphazyme A/S in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% less funds holding
Funds holding: 16 → 5 (-11)
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
95% less capital invested
Capital invested by funds: $35.9M → $1.84M (-$34M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
5
Holders Change
-11
Holders Change %
-68.75%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$57.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$23.7K |
Top Sellers
| 1 |
IM
Islet Management
New York
|
-$14M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5.33M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$5.06M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.07M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.81M |
